Literature DB >> 33120170

Novel aspects on the role of white adipose tissue in type 2 diabetes.

Niklas Mejhert1, Mikael Rydén2.   

Abstract

White adipose tissue (WAT) is a highly dynamic organ that can vary considerably in mass depending on energy balance. Data from recent cross-sectional and prospective clinical studies have revealed a set of mechanisms that link WAT dysfunction to type 2 diabetes. This review focuses on three of the most important pathophysiological processes that distinguish WAT in the insulin resistant state: regional WAT distribution, adipocyte hypertrophy and lipid turnover. Together, these disturbances attenuate the lipid storage capacity of WAT leading to ectopic fat deposition in peripheral tissues such as skeletal muscle, liver and vessels ultimately leading to type 2 diabetes and cardiovascular complications. The possible approaches to therapeutically target dysfunctional WAT are also discussed.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 33120170     DOI: 10.1016/j.coph.2020.09.008

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  3 in total

1.  Impaired phosphocreatine metabolism in white adipocytes promotes inflammation.

Authors:  Salwan Maqdasy; Simon Lecoutre; Niklas Mejhert; Mikael Rydén; Gianluca Renzi; Scott Frendo-Cumbo; David Rizo-Roca; Thomas Moritz; Marta Juvany; Ondrej Hodek; Hui Gao; Morgane Couchet; Michael Witting; Alastair Kerr; Martin O Bergo; Robin P Choudhury; Myriam Aouadi; Juleen R Zierath; Anna Krook
Journal:  Nat Metab       Date:  2022-02-14

Review 2.  Importance of the Microenvironment and Mechanosensing in Adipose Tissue Biology.

Authors:  Simon Lecoutre; Mélanie Lambert; Krzysztof Drygalski; Isabelle Dugail; Salwan Maqdasy; Mathieu Hautefeuille; Karine Clément
Journal:  Cells       Date:  2022-07-27       Impact factor: 7.666

3.  Obesity management: at the forefront against disease stigma and therapeutic inertia.

Authors:  Luca Busetto; Paolo Sbraccia; Roberto Vettor
Journal:  Eat Weight Disord       Date:  2021-05-29       Impact factor: 4.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.